Prognosis of early hepatocellular carcinoma after hepatic resection

Takashi Maeda, Mitsuo Shimada, Norifumi Harimoto, Eiji Tsujita, Shin Ichi Aishima, Shinji Tanaka, Ken Shirabe, Yoshihiko Maehara

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background/Aims: Clinicopathologic characteristics and postoperative prognosis of early hepatocellular carcinoma (eHCC) have not been clarified. Methodology: Early HCC was designated as tumor purely composed of well-differentiated HCC not containing moderately or poorly differentiated component. Twenty seven patients with early HCC among 515 patients underwent hepatic resection for HCC were analyzed. Results: The survival rate at 5 years after hepatic resection of the patients with early HCC was 76%. No clinicopathologic factors correlated with the survival. The postoperative recurrence occurred in 19 (70%) patients, and nine patients survived more than five years free of recurrence. The levels of aspartate aminotransferase and alanine aminotransferase of the patients with recurrence within five years (n=9) were much higher than those of the patients without recurrence (n=18). The prognosis after recurrence of the patients with more than three tumors was significantly worse than that of the patients with one or two tumors (P<0.01). Conclusions: The survival rate of early HCC after hepatic resection is favorable, however, recurrence is considerably frequent and it depends on the degree of inflammation of underling liver disease. Therefore, the control of inflammation of liver parenchyma and the preservation of liver function may be most important in patients with early HCC.

Original languageEnglish
Pages (from-to)1428-1432
Number of pages5
JournalHepato-Gastroenterology
Volume55
Issue number85
Publication statusPublished - Jul 2008

Fingerprint

Hepatocellular Carcinoma
Liver
Recurrence
Survival Rate
Inflammation
Neoplasms
Aspartate Aminotransferases
Alanine Transaminase
Liver Diseases
Survival

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology

Cite this

Maeda, T., Shimada, M., Harimoto, N., Tsujita, E., Aishima, S. I., Tanaka, S., ... Maehara, Y. (2008). Prognosis of early hepatocellular carcinoma after hepatic resection. Hepato-Gastroenterology, 55(85), 1428-1432.

Prognosis of early hepatocellular carcinoma after hepatic resection. / Maeda, Takashi; Shimada, Mitsuo; Harimoto, Norifumi; Tsujita, Eiji; Aishima, Shin Ichi; Tanaka, Shinji; Shirabe, Ken; Maehara, Yoshihiko.

In: Hepato-Gastroenterology, Vol. 55, No. 85, 07.2008, p. 1428-1432.

Research output: Contribution to journalArticle

Maeda, T, Shimada, M, Harimoto, N, Tsujita, E, Aishima, SI, Tanaka, S, Shirabe, K & Maehara, Y 2008, 'Prognosis of early hepatocellular carcinoma after hepatic resection', Hepato-Gastroenterology, vol. 55, no. 85, pp. 1428-1432.
Maeda T, Shimada M, Harimoto N, Tsujita E, Aishima SI, Tanaka S et al. Prognosis of early hepatocellular carcinoma after hepatic resection. Hepato-Gastroenterology. 2008 Jul;55(85):1428-1432.
Maeda, Takashi ; Shimada, Mitsuo ; Harimoto, Norifumi ; Tsujita, Eiji ; Aishima, Shin Ichi ; Tanaka, Shinji ; Shirabe, Ken ; Maehara, Yoshihiko. / Prognosis of early hepatocellular carcinoma after hepatic resection. In: Hepato-Gastroenterology. 2008 ; Vol. 55, No. 85. pp. 1428-1432.
@article{9d42e05176d64ceda5dacd7b9744e636,
title = "Prognosis of early hepatocellular carcinoma after hepatic resection",
abstract = "Background/Aims: Clinicopathologic characteristics and postoperative prognosis of early hepatocellular carcinoma (eHCC) have not been clarified. Methodology: Early HCC was designated as tumor purely composed of well-differentiated HCC not containing moderately or poorly differentiated component. Twenty seven patients with early HCC among 515 patients underwent hepatic resection for HCC were analyzed. Results: The survival rate at 5 years after hepatic resection of the patients with early HCC was 76{\%}. No clinicopathologic factors correlated with the survival. The postoperative recurrence occurred in 19 (70{\%}) patients, and nine patients survived more than five years free of recurrence. The levels of aspartate aminotransferase and alanine aminotransferase of the patients with recurrence within five years (n=9) were much higher than those of the patients without recurrence (n=18). The prognosis after recurrence of the patients with more than three tumors was significantly worse than that of the patients with one or two tumors (P<0.01). Conclusions: The survival rate of early HCC after hepatic resection is favorable, however, recurrence is considerably frequent and it depends on the degree of inflammation of underling liver disease. Therefore, the control of inflammation of liver parenchyma and the preservation of liver function may be most important in patients with early HCC.",
author = "Takashi Maeda and Mitsuo Shimada and Norifumi Harimoto and Eiji Tsujita and Aishima, {Shin Ichi} and Shinji Tanaka and Ken Shirabe and Yoshihiko Maehara",
year = "2008",
month = "7",
language = "English",
volume = "55",
pages = "1428--1432",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "85",

}

TY - JOUR

T1 - Prognosis of early hepatocellular carcinoma after hepatic resection

AU - Maeda, Takashi

AU - Shimada, Mitsuo

AU - Harimoto, Norifumi

AU - Tsujita, Eiji

AU - Aishima, Shin Ichi

AU - Tanaka, Shinji

AU - Shirabe, Ken

AU - Maehara, Yoshihiko

PY - 2008/7

Y1 - 2008/7

N2 - Background/Aims: Clinicopathologic characteristics and postoperative prognosis of early hepatocellular carcinoma (eHCC) have not been clarified. Methodology: Early HCC was designated as tumor purely composed of well-differentiated HCC not containing moderately or poorly differentiated component. Twenty seven patients with early HCC among 515 patients underwent hepatic resection for HCC were analyzed. Results: The survival rate at 5 years after hepatic resection of the patients with early HCC was 76%. No clinicopathologic factors correlated with the survival. The postoperative recurrence occurred in 19 (70%) patients, and nine patients survived more than five years free of recurrence. The levels of aspartate aminotransferase and alanine aminotransferase of the patients with recurrence within five years (n=9) were much higher than those of the patients without recurrence (n=18). The prognosis after recurrence of the patients with more than three tumors was significantly worse than that of the patients with one or two tumors (P<0.01). Conclusions: The survival rate of early HCC after hepatic resection is favorable, however, recurrence is considerably frequent and it depends on the degree of inflammation of underling liver disease. Therefore, the control of inflammation of liver parenchyma and the preservation of liver function may be most important in patients with early HCC.

AB - Background/Aims: Clinicopathologic characteristics and postoperative prognosis of early hepatocellular carcinoma (eHCC) have not been clarified. Methodology: Early HCC was designated as tumor purely composed of well-differentiated HCC not containing moderately or poorly differentiated component. Twenty seven patients with early HCC among 515 patients underwent hepatic resection for HCC were analyzed. Results: The survival rate at 5 years after hepatic resection of the patients with early HCC was 76%. No clinicopathologic factors correlated with the survival. The postoperative recurrence occurred in 19 (70%) patients, and nine patients survived more than five years free of recurrence. The levels of aspartate aminotransferase and alanine aminotransferase of the patients with recurrence within five years (n=9) were much higher than those of the patients without recurrence (n=18). The prognosis after recurrence of the patients with more than three tumors was significantly worse than that of the patients with one or two tumors (P<0.01). Conclusions: The survival rate of early HCC after hepatic resection is favorable, however, recurrence is considerably frequent and it depends on the degree of inflammation of underling liver disease. Therefore, the control of inflammation of liver parenchyma and the preservation of liver function may be most important in patients with early HCC.

UR - http://www.scopus.com/inward/record.url?scp=58149402263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149402263&partnerID=8YFLogxK

M3 - Article

C2 - 18795705

AN - SCOPUS:58149402263

VL - 55

SP - 1428

EP - 1432

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 85

ER -